Subscribe: Market Wire - Medical and Healthcare: Surgery and Treatments
http://img.marketwire.com/rss/mwMHSU.rss
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
announces  company  development  jun  june  marketwired jun  marketwired  medical  new  otc pink  pain  sciences  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Surgery and Treatments

Marketwired - Surgery and Treatments



Marketwired - Surgery and Treatments



Last Build Date: Thu, 22 Jun 2017 16:23:33 EDT

Copyright: Copyright: (C) Marketwired
 



Centralized Adaptive Trial Design Teams Facilitate Communication Between Global & Country-Level Pharma Teams

Thu, 22 Jun 2017 15:41:00 EDT

65% of surveyed global life science teams have a centralized adaptive trial reporting structure




ECPO-Subsidiary Immunotech Laboratories Enters Final Step of Full Commercialization by the BDA post Phase 3 Approval of ITV-1 for HIV/AIDS; Also Announces Issuance of Distribution Agreement for the Ukraine

Thu, 22 Jun 2017 13:24:33 EDT

MONROVIA, CA--(Marketwired - Jun 22, 2017) - Eco Petroleum Solutions, Inc. ((OTC PINK: ECPO) or the "Company") announces that IMMB BG a subsidiary of Immunotech Laboratories, Inc., the Company's subsidiary, has issued an exclusive Distribution Agreement (the "Agreement") for the territory of the Ukraine to LLC Project Development and Implementation Centre Omega ("Omega"). The term of the agreement is for an initial ten-year period with an option to renew the agreement for an additional ten years. The Agreement establishes a price of EUR 3,300 (Euros) per one 8-week cycle of injections or 16 vials. The treatment protocol requires two 8-week cycles of injections administered twice a week with a one-week break between cycles. The ITV-1 treatment will be administered with a combination of different variations of Protease Inhibitors used in the treatment of HIV/AIDS.




Vancouver Medical Spa Joins the World of Facebook

Thu, 22 Jun 2017 13:22:21 EDT

Dr. Kamani plans to share knowledge of medical aesthetic procedures on beloved online platform




UPDATE - Cannabis Science Releases the Chronic Pain CBIS Transdermal Patches to Meet the Overwhelming Demand from Self-Medicating Patients Worldwide as it Continues to Expands its California Dispensary Network

Thu, 22 Jun 2017 08:43:43 EDT

IRVINE, CA--(Marketwired - Jun 22, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its new product-development plans are well underway with the release of the first batch of the CBIS Transdermal Patch in response to an overwhelming response from hundreds chronic pain self-medicating patients worldwide with various chronic pain conditions including Neuropathy, Fibromyalgia, Diabetic Nerve Pain, Back Strains, and others.




Cannabis Science Releases the Chronic Pain CBIS Transdermal Patches to Meet the Overwhelming Demand from Self-Medicating Patients Worldwide as it Continues to Expands its California Dispensary Network

Thu, 22 Jun 2017 08:11:45 EDT

IRVINE, CA--(Marketwired - Jun 22, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its new product-development plans are well underway with the release of the first batch of the CBIS Transdermal Patch in response to an overwhelming response from hundreds chronic pain self-medicating patients worldwide with various chronic pain conditions including Neuropathy, Fibromyalgia, Diabetic Nerve Pain, Back Strains, and others.




Saratoga Springs Plastic Surgeon Named "Best Of" in Region by Readers of Local Paper

Thu, 22 Jun 2017 08:01:00 EDT

Dr. Steven Yarinsky and Saratoga Springs Plastic Surgery, PC have once again been voted "Best Of" by Saratoga Today




Baltimore Plastic Surgeon Reveals Responsive Website with Modern Design

Thu, 22 Jun 2017 08:01:00 EDT

Dr. James Vogel's new website incorporates an updated look, advanced functionality, and expanded informational resources about his plastic surgery practice and procedures




Nemus Bioscience Announces NB1111 Data Presentation at the 27th Annual Symposium of the International Cannabinoid Research Society (ICRS)

Thu, 22 Jun 2017 05:30:00 EDT

Report on Impact of NB1111 on Tissues that Regulate Intraocular Pressure (IOP) in an Animal Normotensive Ocular Model




Tauriga Sciences Inc. Discloses Additional Personal Investment of $55,000 USD from its Chief Executive Officer Seth M. Shaw; Investment Structured as Equity Private Placement Priced at $0.00125

Wed, 21 Jun 2017 13:30:00 EDT

NEW YORK, NY--(Marketwired - Jun 21, 2017) - Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a company engaged in the building of life sciences businesses and technologies, has today announced that is Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has made an additional personal investment into the Company totaling $55,000 USD at this time. This personal investment was once again structured as an equity Private Placement at a price of $0.00125 ("one eighth of one cent"), for a total of 44,000,000 shares (a Form 4 reflecting this insider purchase will be filed within the next several business days). Including the personal investment disclosed last week ($95,000 USD on June 15, 2017), Mr. Shaw has now invested a total of $150,000 USD into the Company at this price of $0.00125 per share; for a total of 120,000,000 shares. The Company will utilize this infusion of working capital for general and administrative purposes; these 44,000,000 shares will not be issued until the Company has successfully amended its Shares Authorized.




Exa Delivers Multispecialty Enterprise Imaging Capabilities Across Envision Diagnostic Center's 11 Facilities

Wed, 21 Jun 2017 11:00:00 EDT

WAYNE, NJ--(Marketwired - June 21, 2017) - Envision Diagnostic Center (Novi, MI) has implemented ExaT PACS from Konica Minolta Healthcare Americas, Inc. to facilitate the sharing of multispecialty medical images and reports while enabling the use of computerized physician order entry (CPOE). Exa provides the infrastructure and flexibility for Envision Diagnostic, a division of the multispecialty Envision Medical Group with 11 locations, to manage data across the imaging workflow in different ways depending on the source of the imaging order. All Envision physician orders are generated through the organization's electronic medical record (EMR) solution with reports sent electronically back to it. Non-Envision physician orders are submitted through Exa's referring physician portal and reports are then faxed back to the provider's office.




ORHub (ORHB) Sets Exercise Price for its Series B and D Warrants

Wed, 21 Jun 2017 10:50:28 EDT

NEWPORT BEACH, CA--(Marketwired - Jun 21, 2017) - ORHub, Inc. (OTC: ORHB), a cloud-based medical software company established as the Operating Room Hub for data and analytics, today announces a $0.50 exercise price for all the Company's Series B & D Warrants.




Nutra Pharma Announcing Launch of Luxury Feet

Wed, 21 Jun 2017 08:30:00 EDT

Nutra Pharma is announcing the launch of Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos




Rennova Health Stockholders Approve Proposal at Special Meeting

Wed, 21 Jun 2017 08:30:00 EDT

WEST PALM BEACH, FL--(Marketwired - June 21, 2017) - Rennova Health, Inc. (NASDAQ: RNVA), (NASDAQ: RNVAZ) ("Rennova" or the "Company"), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announces that its stockholders approved Proposal 1 at a Special Meeting of Stockholders held on June 16, 2017.




Top Pharma Companies Look to Partnerships and Acquisitions to Maximize Resources During Product Development & Commercialization

Tue, 20 Jun 2017 17:57:00 EDT

Study finds that 60% of Top 10 pharma companies look to acquisitions to build their portfolios




Titan Medical Inc. Announces Pricing of Marketed Offering of Units

Tue, 20 Jun 2017 09:54:55 EDT

TORONTO, ON--(Marketwired - June 20, 2017) -




Quotient and Ortho Clinical Diagnostics to Present Symposium on Role of Extended Phenotyping in Blood Matching at ISBT

Tue, 20 Jun 2017 00:00:00 EDT

EYSINS, SWITZERLAND and RARITAN, NJ--(Marketwired - Jun 20, 2017) - Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, and Ortho Clinical Diagnostics ("Ortho"), a global leader of in vitro diagnostics, today announced they will jointly host a company-sponsored satellite symposium, "Improving Patient Care with Better-matched Blood," on Tuesday, June 20 from 12:00-1:30 p.m., during the 27th Regional Congress of the International Society of Blood Transfusion (ISBT). The ISBT Regional Congress takes place this week in Copenhagen, Denmark.




UPDATE - Eco-Petroleum Solutions, Inc. Releases Letter from CEO and Chairman

Mon, 19 Jun 2017 12:51:54 EDT

ECPO Chairman and CEO Addresses Shareholders Informing Them of New Business Model




GeoVax Awarded NIH Grant for Zika Vaccine

Mon, 19 Jun 2017 12:00:00 EDT

Supports Advanced Preclinical Testing in Preparation for Human Clinical Trials




Tauriga Sciences, Inc. Reiterates That it Has No Plans to Enact Any Type of Reverse Split for the Foreseeable Future

Mon, 19 Jun 2017 08:00:00 EDT

NEW YORK, NY--(Marketwired - Jun 19, 2017) -  Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a Company engaged in the building of businesses in the life sciences space, has today confirmed to shareholders that it has no plans to enact any type of Reverse Split for the foreseeable future. This press release has been issued, with Board Approval, in response to numerous shareholders inquiries over the past few weeks. The Company expects that it would only consider enacting a Reverse Split as part of some future merger/acquisition, if both parties would agree that an amendment of the Company's capital structure at that time, would be advantageous to all.




Titan Medical Named Best Canadian IP Department at 2017 International Legal Alliance Summit & Awards

Mon, 19 Jun 2017 07:30:00 EDT

Director of Strategic Development and Intellectual Property Jasminder Brar recognized as a global IP strategy leader by Intellectual Asset Management




Avadim Technologies Engages ASGARD Partners & Co. as Merchant Banking Partner & Strategic Advisor

Fri, 16 Jun 2017 15:25:57 EDT

ASHEVILLE, NC--(Marketwired - June 16, 2017) - Avadim Technologies, Inc. ("Avadim"), the Bionome TherapiesT life sciences company, announced today the engagement of ASGARD Partners & Co. ("ASGARD"), to provide strategic and capital markets advisory services to Avadim.* Based in New York, the partners at ASGARD have collectively arranged and advised on more than $50 billion in transactions and have proven expertise across a wide spectrum of advisory services. ASGARD brings multi-functional capabilities to its clients and enables them to navigate their capital and growth decisions effectively. ASGARD also helps negotiate directly with banks and investors on behalf of their clients.




Tauriga Sciences Inc. Incorporates its New and Improved Label Design for the Upcoming Launch of its Cupuacu Butter Lip Balm Product

Fri, 16 Jun 2017 12:12:11 EDT

NEW YORK, NY--(Marketwired - Jun 16, 2017) - Tauriga Sciences Inc. (OTC PINK: TAUG) ("Tauriga" or "the Company"), a Company engaged in the building of businesses in the life sciences space, has today announced the completion of its new and improved label design and graphics for its Cupuacu Butter lip balm product (HERMAN), taking into account the feedback obtained from potential customers and retailers during the test-marketing phase (January 1, 2017 - April 30, 2017). The final product, which will incorporate this new label design, is expected to be available in the near future. An image of the new label will be uploaded to the Company's corporate website (www.tauriga.com) within the next few days.




Eco-Petroleum Solutions, Inc. Releases Letter from CEO and Chairman

Fri, 16 Jun 2017 12:10:01 EDT

MONROVIA, CA--(Marketwired - Jun 16, 2017) -  Eco Petroleum Solutions, Inc. (OTC PINK: ECPO) published today the first letter to the shareholders from the newly appointed Chief Executive Officer and Chairman of ECPO, Harry Zhabilov.




Mspark Partners with Dear Jack Foundation in Enhanced Augmented Reality Promotion

Fri, 16 Jun 2017 10:30:00 EDT

Integrated Print and Digital Technology Furthers Dear Jack Foundation Mission to Promote Awareness and Support for Adolescents and Young Adults Diagnosed with Cancer




Medovex Corporation Receives First Three Commercial Orders for DenerveX(TM) System

Fri, 16 Jun 2017 09:50:00 EDT

Recently CE Marked and Highly Disruptive Device with Faster Recovery Time than Current Surgical Treatment Options Now Available in Europe




Titan Medical Announces Voting Results From Its Annual and Special Meeting of Shareholders

Fri, 16 Jun 2017 09:00:57 EDT

TORONTO, ON--(Marketwired - June 16, 2017) - Titan Medical Inc. ("Titan" or the "Company") (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery, reported shareholder vote results from the Company's Annual and Special Meeting held on Thursday, June 15, 2017.




GB Sciences Builds Broad Cannabis Patent Portfolio -- CFN Media

Fri, 16 Jun 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Jun 16, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article and interview with CEO John Poss, discussing GB Sciences Inc. (OTCQB: GBLX) and its drug development pipeline for novel cannabis-based therapies.




SANUWAVE Health Appoints Maj-Britt Kaltoft to its Board of Directors; Extensive International and Strategic Partnership Strength Added

Fri, 16 Jun 2017 09:00:00 EDT

SUWANEE, GA--(Marketwired - Jun 16, 2017) - SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Maj-Britt Kaltoft to its Board of Directors. Dr. Kaltoft brings 20 years of international specialization in development and successful execution of business development strategies, contractual structures and alliance management within all sectors of the life science industry. Dr. Kaltoft currently heads the business development and patent functions at the Danish State Serum Institute, an institution under the Danish Ministry of Health. She has obtained outstanding results in the areas of business development, licensing and alliance management in the pharmaceutical and biotech industry at Lundbeck, Nycomed, EffRx and Novo Nordisk. With this appointment, the Company's Board of Directors has expanded to five members.




NetworkNewsWire Announces Publication that Highlights Notable Public Companies in the Alzheimer's Disease Treatment Market

Fri, 16 Jun 2017 06:30:00 EDT

NEW YORK, NY--(Marketwired - Jun 16, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring India Globalization Capital, Inc. (NYSE MKT: IGC), an NNW client positioned as a first mover in developing a portfolio of products using cannabis-based "combination therapies" for the treatment of pain and other conditions, including Alzheimer's disease.




/NOTICE TO DISREGARD - Health Advance Shareholder Update

Thu, 15 Jun 2017 16:25:16 EDT

LAS VEGAS, NV--(Marketwired - Jun 15, 2017) - We are advised by Health Advance, Inc. (OTC PINK: HADV) that journalists and other readers should disregard the news release, "Health Advance Shareholder Update" issued today, June 15, 2017, over Marketwired.